One-year clinical outcomes of everolimus-versus sirolimus-eluting stents in patients with acute myocardial infarction
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, Kang-Yin | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Wang, Lin | - |
dc.contributor.author | Li, Yong-Jian | - |
dc.contributor.author | Li, Guang-Ping | - |
dc.contributor.author | Choi, Cheol Ung | - |
dc.contributor.author | Park, Chang Gyu | - |
dc.contributor.author | Seo, Hong Seog | - |
dc.contributor.author | Oh, Dong Joo | - |
dc.contributor.author | Jeong, Myung Ho | - |
dc.contributor.author | Ahn, Young Keun | - |
dc.contributor.author | Hong, Taek Jong | - |
dc.contributor.author | Kim, Young Jo | - |
dc.contributor.author | Chae, Shung Chull | - |
dc.contributor.author | Hur, Seung Ho | - |
dc.contributor.author | Seong, In Whan | - |
dc.contributor.author | Chae, Jei Keon | - |
dc.contributor.author | Cho, Myeong Chan | - |
dc.contributor.author | Bae, Jang Ho | - |
dc.contributor.author | Choi, Dong Hoon | - |
dc.contributor.author | Jang, Yang Soo | - |
dc.contributor.author | Chae, In Ho | - |
dc.contributor.author | Kim, Hyo Soo | - |
dc.contributor.author | Kim, Chong Jin | - |
dc.contributor.author | Yoon, Jung Han | - |
dc.contributor.author | Ahn, Tae Hoon | - |
dc.contributor.author | Chung, Wook Sung | - |
dc.contributor.author | Seung, Ki Bae | - |
dc.contributor.author | Park, Seung Jung | - |
dc.date.accessioned | 2021-09-05T04:02:27Z | - |
dc.date.available | 2021-09-05T04:02:27Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-10-20 | - |
dc.identifier.issn | 0167-5273 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/97078 | - |
dc.description.abstract | Background: In contrast to many studies comparing everolimus-eluting stent (EES) with paclitaxel-eluting stent (PES), data directly comparing EES with sirolimus-eluting stent (SES) are limited, especially in patients with acute myocardial infarction (AMI). Methods: This study includes 2911 AMI patients treated with SES (n = 1264) or EES (n = 1701) in Korea Acute Myocardial Infarction Registry (KAMIR). Propensity score matching was applied to adjust for baseline imbalance in clinical and angiographic characteristics, yielding a total of 2400 well-matched patients (1200 receiving SES and 1200 receiving EES). One-year clinical outcomes were compared between the two propensity score matched groups. Results: Baseline clinical and angiographic characteristics were similar between the two propensity score matched groups One-year clinical outcomes of the propensity score matched cohort were comparable between the EES versus the SES groups including the rates of cardiac death (4.8% vs. 4.8%, P = 1.000), recurrent myocardial infarction (1.4% vs. 1.7%, P = 0.619), target lesion revascularization (1.4% vs. 1.6%, P = 0.737), target lesion failure (7.0% vs. 7.3%, P = 0.752), and probable or definite stent thrombosis (0.5% vs. 0.9%, P = 0.224) except for a trend toward lower incidence of target vessel revascularization (1.9% vs. 3.0%, P = 0.087) and a lower rate of total major adverse cardiac events (9.3% vs. 11.9%, P = 0.034) in the EES group. Conclusions: The present propensity score matched analysis performed in a large-scale, prospective, multicenter registry suggests that the second-generation drug-eluting stent EES has at least comparable or even better safety and efficacy profiles as compared with SES in the setting of AMI. (C) 2014 Elsevier Ireland Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.subject | CORONARY-ARTERY-DISEASE | - |
dc.subject | RANDOMIZED-TRIALS | - |
dc.subject | UNRESTRICTED USE | - |
dc.subject | METAANALYSIS | - |
dc.subject | EFFICACY | - |
dc.subject | CYPHER | - |
dc.title | One-year clinical outcomes of everolimus-versus sirolimus-eluting stents in patients with acute myocardial infarction | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Rha, Seung-Woon | - |
dc.contributor.affiliatedAuthor | Choi, Cheol Ung | - |
dc.contributor.affiliatedAuthor | Park, Chang Gyu | - |
dc.contributor.affiliatedAuthor | Seo, Hong Seog | - |
dc.contributor.affiliatedAuthor | Oh, Dong Joo | - |
dc.identifier.doi | 10.1016/j.ijcard.2014.08.049 | - |
dc.identifier.scopusid | 2-s2.0-84908151173 | - |
dc.identifier.wosid | 000343893300029 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF CARDIOLOGY, v.176, no.3, pp.583 - 588 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF CARDIOLOGY | - |
dc.citation.title | INTERNATIONAL JOURNAL OF CARDIOLOGY | - |
dc.citation.volume | 176 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 583 | - |
dc.citation.endPage | 588 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | CORONARY-ARTERY-DISEASE | - |
dc.subject.keywordPlus | RANDOMIZED-TRIALS | - |
dc.subject.keywordPlus | UNRESTRICTED USE | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | CYPHER | - |
dc.subject.keywordAuthor | Acute myocardial infarction | - |
dc.subject.keywordAuthor | Everolimus-eluting stents | - |
dc.subject.keywordAuthor | Sirolimus-eluting stents | - |
dc.subject.keywordAuthor | Percutaneous coronary intervention | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.